Bank of New York Mellon’s Cellectis CLLS Stock Holding History

Bank of New York Mellon’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,000	Closed	-$262K	–	4402
2021 Q1	$262K	Buy	+13,000	New	+$321K	﹤0.01%	3964
2016 Q2	–	Sell	-8,130	Closed	-$224K	–	4326
2016 Q1	$224K	Buy	8,130 +134	+2%	+$3.23K	﹤0.01%	3751
2015 Q4	$248K	Buy	+7,996	New	+$243K	﹤0.01%	3794

Other funds holding CLLS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Bank of New York Mellon's CLLS Position: Q2 2021 in Review

Bank of New York Mellon sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 13,000 shares — an estimated $262K sold.

Bank of New York Mellon first reported a position in CLLS in Q4 2015 and held it in 3 quarters. The position peaked at $262K in Q1 2021. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.

Bank of New York Mellon reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
Bank of New York Mellon sold 13,000 Cellectis shares in Q2 2021, an estimated $262K.
Bank of New York Mellon first reported a position in Cellectis in Q4 2015 and held it in 3 quarters.
Bank of New York Mellon's Cellectis position peaked at $262K in Q1 2021.
78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.